RECENT NEWS

Research published in the Journal of Parkinson's Disease shows promise for finding an objective, quantifiable, less-invasive biomarker for diagnosing Parkinson's disease.

National charity Group B Strep Support has produced a new free eLearning module on group B Streptococcus (GBS), to be used as a vital resource for midwives, doctors and health professionals in maternity services. It offers vital evidence-based education on GBS to enhance the care of pregnant women and people, and their babies, and ultimately will help save lives.

Do-it-yourself human papillomavirus (HPV) tests could allow an extra one million women in England to participate in cervical screening over the next three years.

Bio-Rad Laboratories has expanded its Pioneer Antibody Discovery Platform services with the addition of fast generation and screening of bispecific antibodies, based on the company’s proprietary SpyLock technology.

Thermo Fisher Scientific recently announced that it has been 510k cleared, following US Food and Drug Administration (FDA) requirements, to market its Optilite Freelite assays’ claim for the evaluation of monoclonal gammopathy of undetermined significance (MGUS).

Agilent Technologies has received US Food and Drug Administration (FDA) approval for the use of MAGE-A4 IHC 1F9 pharmDx (SK032) as a diagnostic tool to aid in identifying patients with synovial sarcoma who may be eligible for treatment with TECELRA (afamitresgene autoleucel, also known as afami-cel or ADP-A2M4), a MAGE-A4-directed engineered TCR T-cell therapy.

INTEGRA’s innovative MAG and HEATMAG modules are designed to overcome problems with repetitive magnetic bead clean-up by automating the movement of a magnet to capture magnetic beads, simplifying proteomics and molecular biology laboratory preparation protocols.

Torrey Pines Scientific has launched its EchoTherm Model IC50 Peltier driven Chilling/Heating Dry Bath with exact sample temperature control.

An independent review of the Care Quality Commission (CQC) has identified significant internal failings which is hampering its ability to identify poor performance at hospitals, care homes and GP practices.

Cambridge scientists have developed an artificially-intelligent tool capable of predicting in four cases out of five whether people with early signs of dementia will remain stable or develop Alzheimer’s disease.

A new report from IBMS and Abbott, ‘Community Diagnostics: Scaling Point-of-Care Testing for Patient-Centred Outcomes’ provides a POCT roadmap for the new government, healthcare organisations and primary care providers.

London pathology services provider Synnovis is continuing to recover services following the cyber attack on 3 June.

Sophia Genetics has announced that OncoHelix, an internationally recognised research and diagnostics laboratory for precision diagnostics, will implement MSK-ACCESS powered with SOPHiA DDM. The organisation, which currently uses the SOPHiA DDM platform for myeloid testing, will use the new liquid biopsy solution to advance its oncology testing capabilities.

BD (Becton Dickinson) and Quest Diagnostics have announced a global collaboration agreement to develop, manufacture and commercialise flow cytometry-based companion diagnostics (CDx) intended to help select the best treatment for patients with cancer and other diseases.

Proscia has introduced the next version of its enterprise pathology platform Concentriq AP. The release includes new functionality that advances the impact of AI in shaping pathologists’ understanding of four of the top five most common cancers worldwide.

The Institute of Biomedical Science (IBMS) has backed the conclusions and recommendations from the UK COVID-19 Inquiry’s first report, which include comprehensive and multidisciplinary planning, the involvement of a broader range of experts and a new independent statutory body responsible for whole system preparedness and response,

The next Pro-Lab Diagnostics scientific webinar will be ‘The second 5-year national antimicrobial resistance action plan: what's new’. An update on the UK’s 20-year vision for confronting antimicrobial resistance, it takes place on Tuesday 30 July, 12 noon – 1.00 pm.

In a collaborative project led by the University of Oxford, diagnostic artificial intelligence (AI) applications from Paige are being trialled as part of a live, multisite clinical use study to evaluate AI in the diagnosis of prostate cancer within the NHS.

The Chair of the UK Covid-19 Inquiry, Baroness Heather Hallett, is urging the new UK government and the governments of Wales, Scotland and Northern Ireland to implement promptly her 10 key recommendations following publication of the Inquiry’s report of its first investigation into the nation’s resilience and preparedness for the pandemic.

The UK will become the first country in the world to have a national programme that uses the same vaccine to protect newborns and also older adults against respiratory syncytial virus (RSV).